Meningococcal vaccines including hemoglobin receptor

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/095 (2006.01) C07K 19/00 (2006.01) C12N 1/20 (2006.01)

Patent

CA 2747340

The meningococcal haemoglobin receptor, HmbR, is used as a vaccine antigen in combination with one or more further antigens e.g. in combination with a meningococcal outer membrane vesicle, with another purified meningococcal antigen (e.g. fHBP, 287, NadA, NspA, NhhA, App, Omp85, LOS), with a conjugated meningococcal capsular saccharide, etc.

Selon l'invention, le récepteur de l'hémoglobine méningococcique, HmbR, est utilisé en tant qu'antigène vaccinal combiné avec un ou plusieurs autres antigènes, par exemple combiné à une vésicule membranaire externe méningococcique, à un autre antigène méningococcique purifié (par exemple, fHBP, 287, NadA, NspA, NhhA, App, Omp85, LOS), à un saccharide capsulaire méningococcique conjugué etc.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Meningococcal vaccines including hemoglobin receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Meningococcal vaccines including hemoglobin receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Meningococcal vaccines including hemoglobin receptor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2076296

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.